250 MG Abiraterone Acetate Tablets IP
6900 INR/Unit
Product Details:
- Dosage Form Tablet
- Origin India
- Ingredients Other
- Application Other
- Storage Instructions Dry Place
- Click to View more
X
250 MG Abiraterone Acetate Tablets IP Price And Quantity
- 10 Unit
- 6900 INR/Unit
250 MG Abiraterone Acetate Tablets IP Product Specifications
- India
- Tablet
- Dry Place
- Other
- Other
250 MG Abiraterone Acetate Tablets IP Trade Information
- Cash in Advance (CID)
- 5000 Unit Per Month
- 7-10 Days
- All India
Product Description
250 MG Abiraterone Acetate Tablets IP are manufactured in India and contain the active ingredient Abiraterone Acetate. These tablets are used in the treatment of prostate cancer and work by reducing androgen production in the body. The recommended dosage form of the tablets is oral, and they should be stored in a dry place to maintain their efficacy. As a distributor, exporter, importer, manufacturer, service provider, supplier, and trader, we ensure the highest quality standards for our products.
FAQs of 250 MG Abiraterone Acetate Tablets IP:
Q: What is the recommended dosage form for these tablets?
A: The recommended dosage form for these tablets is oral.Q: What is the active ingredient in 250 MG Abiraterone Acetate Tablets IP?
A: The active ingredient in these tablets is Abiraterone Acetate.Q: What is the primary use of these tablets?
A: These tablets are primarily used in the treatment of prostate cancer.Q: Where are these tablets manufactured?
A: These tablets are manufactured in India.Q: How should these tablets be stored?
A: These tablets should be stored in a dry place to maintain their efficacy.Enter Buying Requirement Details
Other Products in 'Oncology Medicine' category
UJWALA PHARMACEUTICAL
GST : 27AFRPT3648D1ZZ
GST : 27AFRPT3648D1ZZ
Contact Details
- Ground Floor, 8, Netaji Nagar Chsg Ltd, Lula Nagar Road, Wanwadi,Pune - 411040, Maharashtra, India
- Phone : 07317186335
- Mrs. Darshana (Proprietor)
- Mobile : 07317186335
UJWALA PHARMACEUTICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese